Related Experiment Videos
Homocysteine
Robert Hasty1, Edward N Smolar
1Miami Heart Institute/Mt. Sinai Medical Center, Miami, FL, USA.
Comprehensive Therapy
|March 16, 2002
Insights
Homocysteine is linked to increased cardiovascular disease and death. This review covers its epidemiology, causes, diagnosis, and treatment strategies.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Homocysteine is an amino acid metabolite implicated in cardiovascular pathology.
- Elevated homocysteine levels contribute significantly to cardiovascular morbidity and mortality.
Purpose of the Study:
- To provide a comprehensive overview of homocysteine's role in cardiovascular disease.
- To discuss the epidemiology, pathophysiology, diagnostics, and treatment of hyperhomocysteinemia.
Main Methods:
- Literature review of epidemiological, pathophysiological, and clinical studies.
- Synthesis of current knowledge on homocysteine metabolism and cardiovascular impact.
Main Results:
- Homocysteine is a significant risk factor for cardiovascular events.
- Understanding its epidemiology and pathophysiology is crucial for risk assessment.
Conclusions:
- Hyperhomocysteinemia requires clinical attention due to its association with cardiovascular disease.
- Further research and clinical guidelines are needed for effective management.
Abstract:
Homocystemia is a pathological condition that represents a significant role in cardiovascular morbidity and mortality. The epidemiology, pathophysiology, and clinical diagnostics and treatment aspects are described and discussed.